Ardent Health, Inc. (ARDT) — SEC Filings
Ardent Health, Inc. (ARDT) — 28 SEC filings. Latest: DEFA14A (Apr 8, 2026). Includes 12 8-K, 5 10-Q, 3 SC 13G.
View Ardent Health, Inc. on SEC EDGAR
Overview
Ardent Health, Inc. (ARDT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 14, 2025: Ardent Health, Inc. (ARDT) reported a significant net loss attributable to the company of $23.478 million for the three months ended September 30, 2025, a sharp decline from a net income of $26.322 million in the prior-year quarter. Despite this, total revenue increased by 8.75% to $1.576 billion fr
Sentiment Summary
Across 28 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 26 neutral. The dominant filing sentiment for Ardent Health, Inc. is neutral.
Filing Type Overview
Ardent Health, Inc. (ARDT) has filed 1 4, 1 DEFA14A, 12 8-K, 5 10-Q, 1 DEF 14A, 1 10-K, 3 SC 13G, 3 S-1/A, 1 S-1 with the SEC between Jun 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (28)
Risk Profile
Risk Assessment: Of ARDT's 21 recent filings, 1 were flagged as high-risk, 13 as medium-risk, and 7 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $1.576B |
| Net Income | -$23.478M |
| Cash Position | $609.441M |
| Total Debt | $1.087B |
Key Executives
- Martin J. Bonick
Industry Context
Ardent Health operates within the highly competitive and regulated U.S. healthcare services industry. The sector is characterized by increasing demand for services, driven by an aging population and advancements in medical technology, but also faces significant cost pressures from labor, supplies, and reimbursement changes.
Top Tags
healthcare (8) · financial-reporting (4) · financials (4) · 10-Q (3) · Healthcare (2) · compensation (2) · 8-k (2) · sec-filing (2) · corporate-conversion (2) · corporate-restructuring (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss Attributable to ARDT | $23.478M | Q3 2025, a significant decline from $26.322M net income in Q3 2024 |
| Total Revenue | $1.576B | Q3 2025, an 8.75% increase from $1.449B in Q3 2024 |
| Other Operating Expenses | $198.714M | Q3 2025, a 68.8% increase from $117.700M in Q3 2024 |
| Loss on Debt Extinguishment | $7.344M | Q3 2025, up from $1.490M in Q3 2024 |
| Salaries and Benefits | $676.962M | Q3 2025, a 6.57% increase from $635.223M in Q3 2024 |
| Net Income Attributable to ARDT (YTD) | $90.855M | Nine months ended Sept 30, 2025, down from $96.139M in prior year |
| Total Revenue (YTD) | $4.719B | Nine months ended Sept 30, 2025, an 8.25% increase from $4.359B in prior year |
| Cash and Cash Equivalents | $609.441M | As of Sept 30, 2025, up from $556.785M at Dec 31, 2024 |
| Long-term Debt | $1.087B | As of Sept 30, 2025, relatively stable from $1.085B at Dec 31, 2024 |
| Common Shares Outstanding | 143,187,681 | As of November 7, 2025 |
| Commission File Number | 001-42180 | Identifies the company's SEC filing history |
| I.R.S. Employer Identification No. | 61-1764793 | Company's tax identification number |
| Revenue | $2.8B | for the six months ended June 30, 2025, up 12% from $2.5B in the prior year |
| Revenue Growth | 12% | year-over-year increase for the six months ended June 30, 2025 |
| SEC File Number | 001-42180 | Identifies the company's filing with the SEC. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Ardent Health, Inc. (ARDT)?
Ardent Health, Inc. has 28 recent SEC filings from Jun 2024 to Apr 2026, including 12 8-K, 5 10-Q, 3 SC 13G. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of ARDT filings?
Across 28 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 26 neutral. The dominant sentiment is neutral.
Where can I find Ardent Health, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Ardent Health, Inc. (ARDT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Ardent Health, Inc.?
Key financial highlights from Ardent Health, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for ARDT?
The investment thesis for ARDT includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Ardent Health, Inc.?
Key executives identified across Ardent Health, Inc.'s filings include Martin J. Bonick.
What are the main risk factors for Ardent Health, Inc. stock?
Of ARDT's 21 assessed filings, 1 were flagged high-risk, 13 medium-risk, and 7 low-risk.
What are recent predictions and forward guidance from Ardent Health, Inc.?
Forward guidance and predictions for Ardent Health, Inc. are extracted from SEC filings as they are enriched.